Roivant

Roivant is a New York-based biotechnology company that researches and develops novel therapies for the treatment of neurological and endocrine diseases.

Business Model:

Revenue: $18.9M

Employees: 501-1,000

Detailed Roivant Information

Geographic Data

Roivant headquarters map

Address: 151 W 42nd Street

City: New York

State: NY

Zip: 10036

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$200M

Raised Total:

$2B

Metrics

1,765,446Website Global Rank

12,906Website Monthly Traffic

Twitter Followers

Description

Roivant is a New York-based biotechnology company that researches and develops novel therapies for the treatment of neurological and endocrine diseases.

Contact Phone:

Contact Email:

Roivant went public on 10/1/2021 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
10/1/2021

IPO Valuation:
$7B

Ticker Symbol:
ROIV

Amount Raised:
$611M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
10/2017 Arbutus Biopharma Post-IPO Equity 116.4M
11/2021 Medallion Series B 0
8/2021 Immunovant Corporate Round 200M
4/2018 Datavant Equity 40.5M
10/2020 Datavant Series B 40M
12/2022 Lokavant Series A 21M
11/2021 gen-t Pre Seed Round 2M
11/2021 Medallion Series B 0
11/2021 gen-t Pre Seed Round 0
8/2021 Immunovant Post-IPO Equity 0
10/2020 Datavant Series B 0
4/2018 Datavant Venture Round 0
10/2017 Arbutus Biopharma Post-IPO Equity 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Announced Date Transaction Number of Investors Money Raised Lead Investors
5/2014 Private Equity Round $0 QVT Financial
Dexcel Pharma
Sahsen Ventures
QVT Financial
Dexcel Pharma
Sahsen Ventures
7/2016 Private Equity Round 1 $500M Viking Global Investors
Viking Global Investors
9/2019 Equity -
11/2022 Secondary Offering $150M
12/2020 Corporate Round $200M SK Holding
8/2017 Private Equity Round 2 $1.1B SoftBank Vision Fund
Founders Fund
SoftBank Vision Fund
10/2021 Post-IPO Equity $0 Dainippon Sumitomo Pharma
Eventide
Fidelity Management and Research Company
Palantir Technologies
Patient Square Capital
RTW Investments LLC
SoftBank Capital
Suvretta Capital Management
Viking Global Investors
Dainippon Sumitomo Pharma
Eventide
Fidelity Management and Research Company
Palantir Technologies
Patient Square Capital
RTW Investments LLC
SoftBank Capital
Suvretta Capital Management
Viking Global Investors
11/2018 Private Equity Round $0 Novaquest Capital Management
Novaquest Capital Management
RTW Investments LLC
Dexcel Pharma
Founders Fund
QVT Financial
SoftBank Vision Fund
Viking Global Investors
Novaquest Capital Management
Novaquest Capital Management
RTW Investments LLC
Dexcel Pharma
Founders Fund
QVT Financial
SoftBank Vision Fund
Viking Global Investors
2/2023 Post-IPO Equity $200M
9/2019 Equity - Sumitomo Dainippon
Sumitomo Dainippon
11/2018 Equity 7 $200M Novaquest Capital Management
RTW Investments
Novaquest Capital Management
Novaquest Capital Management
RTW Investments LLC
10/2021 Post-IPO Equity 9 $200M Dainippon Sumitomo Pharma
Eventide
Fidelity Management and Research Company
Palantir Technologies
Patient Square Capital
RTW Investments LLC
SoftBank Capital
Suvretta Capital Management
Viking Global Investors
Dainippon Sumitomo Pharma
Eventide
Fidelity Management and Research Company
Palantir Technologies
Patient Square Capital
RTW Investments LLC
SoftBank Capital
Suvretta Capital Management
Viking Global Investors
5/2014 Private Equity Round 3 $93M QVT Financial
QVT Financial
Announced Date Name Price
2/2021 Silicon Therapeutics

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research